{"id":236,"date":"2023-10-20T15:10:12","date_gmt":"2023-10-20T15:10:12","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-support\/?p=236"},"modified":"2023-10-20T15:10:12","modified_gmt":"2023-10-20T15:10:12","slug":"us-fda-cosmetics-responsible-person","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-support\/2023\/10\/20\/us-fda-cosmetics-responsible-person\/","title":{"rendered":"US FDA Cosmetics Responsible Person"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">As per US FDA\u2019s new regulation for regulating cosmetic\nindustry \u2013 <a href=\"https:\/\/www.fdahelp.us\/fda-mocra-registration-listing-cosmetic-facility.html\">MoCRA<\/a>\n(Modernization of Cosmetics Regulation Act of 2022), FDA now requires cosmetic\ncompanies to <a href=\"https:\/\/www.fdahelp.us\/fda-cosmetic-registration.html\">register\ntheir facility<\/a> and list the cosmetic products with FDA.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The FD&amp;C Act defines <a href=\"https:\/\/www.fdahelp.us\/cosmetics.html\">cosmetics<\/a> as articles intended\nto be applied to the human body for cleansing, beautifying, promoting\nattractiveness, or altering the appearance without affecting the body&#8217;s\nstructure or functions. Some examples are listed <a href=\"https:\/\/www.fdahelp.us\/Pdf\/mocra-product-category.pdf\">here<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">MoCRA defines a Responsible Person as the manufacturer,\npacker, or distributor of a cosmetic product whose name appears on the label of\nsuch cosmetic product in accordance with section 609(a) of the FD&amp;C Act or\nsection 4(a) of the Fair Packaging and Labeling Act.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Under MoCRA, the Responsible Person will have following\nresponsibilities:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>To obtain the relevant facility registration\nnumber or where small business exemption applies, the facility name &amp;\naddress, for each facility where its cosmetic products are manufactured or\nprocessed <\/li><li>Submit product listing for each marketed\ncosmetic product with FDA, including product ingredients, and provide any\nupdates annually.<\/li><li>Reporting serious adverse events associated with\nthe use of cosmetic products in the US to FDA within 15 business days. If the\nresponsible person receives medical or other information about the adverse\nevent within 1 year of the initial report to FDA, they must submit this new\ninformation to FDA within 15 business days. <\/li><li>To ensure and maintain records supporting\nadequate safety substantiation of their cosmetic products.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><em><a href=\"https:\/\/www.fdahelp.us\/\">Liberty Management\nGroup Ltd.<\/a> provides assistance with Cosmetic Facility Registration and Cosmetic\nProduct Listing. <\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Namrata <\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Regulatory Consultant<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>support@libertymanagement.us<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">http:\/\/www.fdahelp.us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As per US FDA\u2019s new regulation for regulating cosmetic industry \u2013 MoCRA (Modernization of Cosmetics Regulation Act of 2022), FDA now requires cosmetic companies to register their facility and list the cosmetic products with FDA. The FD&amp;C Act defines cosmetics as articles intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-support\/2023\/10\/20\/us-fda-cosmetics-responsible-person\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;US FDA Cosmetics Responsible Person&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[12,80,70],"class_list":["post-236","post","type-post","status-publish","format-standard","hentry","category-cosmetics-regulations","tag-cosmetic","tag-cosmetic-listing","tag-mocra"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/comments?post=236"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/236\/revisions"}],"predecessor-version":[{"id":237,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/236\/revisions\/237"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/media?parent=236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/categories?post=236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/tags?post=236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}